Procter & Gamble Health Limited (BOM:500126)
India · Delayed Price · Currency is INR 5,446.45
+5.00 (0.09%)
At close: Jan 20, 2026
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 89.85 billion as of January 23, 2026. Its market cap has increased by 3.99% in one year.
Market Cap
89.85B
Enterprise Value
87.05B
Revenue
12.84B
Ranking
n/a
PE Ratio
29.32
Stock Price
5,446.45
Market Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 89.85B, an increase of 821.91%. That is a compound annual growth rate of 8.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 89.85B | -5.06% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 297.75B |
| AstraZeneca Pharma India | 208.68B |
| Jubilant Pharmova | 153.37B |
| Granules India | 138.61B |
| Caplin Point Laboratories | 131.86B |
| Rubicon Research | 109.49B |
| Sanofi India | 93.40B |
| Viyash Scientific | 87.71B |